U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07627464) titled 'Anlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial Nephrectomy' on May 20.
Brief Summary: Evaluation of long-term renal function improvement, surgical safety, as well as efficacy and safety of preoperative anlotinib hydrochloride capsules combined with benmelstobart injection versus surgery in patients with localized renal cell carcinoma undergoing partial nephrectomy
Study Start Date: May 31
Study Type: INTERVENTIONAL
Condition:
Renal Cell Carcinoma (RCC)
Intervention:
DRUG: Anlotinib hydrochloride + Benmelstobart + Partial nephrectomy
Patients receive neoadjuvan...